GTBPVSIPEX• 6 Months (Normalized)
GTBP vs IPEX (GT Biopharma Inc. vs Inflection Point Acquisition Corp. V)
Showing Closing Date Range from Apr 2 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
IPEX Performance $3.16
-69.59%
Inflection Point Acquisition Corp. V
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+69.59 pts
GTBP outperforming by 69.59 percentage points
GTBPIPEX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP IPEX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(120 dates)
| Date | GTBP Price | GTBP Gain (%) | IPEX Price | IPEX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $- | $3.16 | -69.59% | - | |
| Sep 23, 2026 | $7.10 | +1477.78% | $9.30 | -10.49% | +1488.27% |
| Sep 21, 2026 | $7.18 | +1495.56% | $10.23 | -1.59% | +1497.15% |
| Sep 18, 2026 | $7.16 | +1491.11% | $9.82 | -5.49% | +1496.60% |
| Sep 17, 2026 | $7.49 | +1564.44% | $10.38 | -0.14% | +1564.58% |
| Sep 16, 2026 | $7.81 | +1635.56% | $9.88 | -4.91% | +1640.47% |
| Sep 15, 2026 | $9.00 | +1900.00% | $10.39 | +0.00% | +1900.00% |
| Sep 14, 2026 | $11.63 | +2484.44% | $8.58 | -17.42% | +2501.86% |
| Sep 11, 2026 | $8.61 | +1813.33% | $8.10 | -22.04% | +1835.37% |
| Sep 10, 2026 | $6.18 | +1273.33% | $8.58 | -17.42% | +1290.75% |
| Sep 09, 2026 | $5.98 | +1228.89% | $9.18 | -11.65% | +1240.54% |
| Sep 08, 2026 | $- | $8.49 | -18.29% | - | |
| Sep 04, 2026 | $0.24 | -46.44% | $7.75 | -25.41% | -21.03% |
| Sep 03, 2026 | $0.25 | -44.00% | $10.92 | +5.10% | -49.10% |
| Sep 02, 2026 | $0.28 | -37.11% | $11.00 | +5.87% | -42.98% |
Page 1 of 8